Literature DB >> 16412576

Early induction of calpains in rotenone-mediated neuronal apoptosis.

Minghui Jessica Chen1, Yann Wan Yap, Meng Shyan Choy, Chor Hui Vivien Koh, Sze Jee Seet, Wei Duan, Matthew Whiteman, Nam Sang Cheung.   

Abstract

Rotenone is an inhibitor of mitochondrial complex I that produces a model of Parkinson's disease (PD), where neurons undergo apoptosis by caspase-dependent and/or caspase-independent pathways. Inhibition of calpains has recently been shown to attenuate neuronal apoptosis. This study aims to establish for the first time, the time-point of calpain activation with respect to the caspase activation and the possibility of cell cycle re-entry in rotenone-mediated cell death. Immunoblot results revealed calpain activation occurred at 5, 10h prior to caspase-3 activation (at 15 h), suggesting calpain activation was an earlier cellular event compared to caspase activation in the rotenone-mediated apoptosis. In addition, an upregulation of phospho-p53 was observed at 21 h. However, no expression or upregulation of cell cycle regulatory proteins including cdc25a, cyclin-D1 and cyclin-D3 were observed, strongly suggesting that cell cycle re-entry did not occur. These findings provide new insights into the differential patterns of calpain and caspase activation that result from rotenone poisoning and which may be relevant to the therapeutic management of PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412576     DOI: 10.1016/j.neulet.2005.12.011

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease.

Authors:  Irmgard Paris; Sergio Cardenas; Jorge Lozano; Carolina Perez-Pastene; Rebecca Graumann; Alejandra Riveros; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

2.  Bcl-2 is a novel interacting partner for the 2-oxoglutarate carrier and a key regulator of mitochondrial glutathione.

Authors:  Heather M Wilkins; Kristin Marquardt; Lawrence H Lash; Daniel A Linseman
Journal:  Free Radic Biol Med       Date:  2011-11-09       Impact factor: 7.376

3.  Probes of the mitochondrial cAMP-dependent protein kinase.

Authors:  Jennifer R Shell; David S Lawrence
Journal:  Biochim Biophys Acta       Date:  2013-02-11

4.  Degradation of spectrin via calpains in the ventral horn after transient spinal cord ischemia in rabbits.

Authors:  Jae-Chul Lee; In Koo Hwang; Ki-Yeon Yoo; Doung Shoo Kim; Won-Ki Kim; Moo Ho Won
Journal:  Neurochem Res       Date:  2006-07-18       Impact factor: 3.996

Review 5.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

Review 6.  Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.

Authors:  P S Vosler; C S Brennan; J Chen
Journal:  Mol Neurobiol       Date:  2008-08-07       Impact factor: 5.590

7.  The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats.

Authors:  S Samantaray; V H Knaryan; M K Guyton; D D Matzelle; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2007-03-23       Impact factor: 3.590

8.  Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis.

Authors:  Qian Zhou; Chunxiao Liu; Wen Liu; Hai Zhang; Ruijie Zhang; Jia Liu; Jinfei Zhang; Chong Xu; Lei Liu; Shile Huang; Long Chen
Journal:  Toxicol Sci       Date:  2014-10-09       Impact factor: 4.849

9.  Transcriptome analysis of a rotenone model of parkinsonism reveals complex I-tied and -untied toxicity mechanisms common to neurodegenerative diseases.

Authors:  Yofre Cabeza-Arvelaiz; Robert H Schiestl
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

10.  Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD.

Authors:  A R Esteves; D M Arduíno; D F F Silva; C R Oliveira; S M Cardoso
Journal:  Parkinsons Dis       Date:  2011-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.